Please try another search
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP.
Name | Age | Since | Title |
---|---|---|---|
Janmejay Rajnikant Vyas | 71 | 2007 | Chairman of the Board |
Deohooti Janmejay Vyas | 71 | 2017 | Whole Time Director |
Arpit Janmejay Vyas | 36 | 2012 | Global MD & Director |
Maitri Kirankumar Mehta | 43 | 2019 | Independent Director |
Subir Kumar Das | 71 | 2017 | Independent Director |
Rajendra Shantilal Shah | 76 | 2017 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review